Managing the low-socioeconomic-status prostate cancer patient

Journal of the National Medical Association

Volumn 98, Issue 4, 2006, Pages 520-530

  Rayford, Walter ^a,b,c  

^a Louisiana State University Health Sciences Center ^*

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Urology   (United States)

Author keywords

Education; Literacy; Prostate cancer; Socioeconomic status

Indexed keywords

CARBOPLATIN; DOCETAXEL; DOXORUBICIN; ESTRAMUSTINE; ETOPOSIDE; MITOXANTRONE; PACLITAXEL; PREDNISONE; VINBLASTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CRYOSURGERY; DECISION MAKING; EARLY DIAGNOSIS; EDUCATION PROGRAM; EXTERNAL BEAM RADIOTHERAPY; HEALTH CARE MANAGEMENT; HEALTH CARE PERSONNEL; HUMAN; OUTCOMES RESEARCH; PATIENT PARTICIPATION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROSTATE CANCER; PROSTATECTOMY; SOCIOECONOMICS; EDUCATIONAL STATUS; MALE; NURSE PRACTITIONER; PATIENT EDUCATION; PROSTATE TUMOR; REVIEW; SOCIAL CLASS;

DECISION MAKING; EDUCATIONAL STATUS; HUMANS; MALE; NURSE PRACTITIONERS; PATIENT EDUCATION; PROSTATIC NEOPLASMS; SOCIAL CLASS; SOCIOECONOMIC FACTORS;

EID: 84858577408     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Scherr D, Swindle PW, Scordino PT, National Comprehensive Cancer Network. National Comprehensive Cancer Network guidelines for the management of prostate cancer. Urology. 2003:61 (2 Suppl 1):14-24.
2. Klimberg I, Locke DR, Madore RA, et al. Early prostate cancer: is there a need for new treatment options? Urol Oncol. 2003;21(2):105-116.
3. Yan Y, Carvalhal GF, Catalona WJ, et al. Primary treatment choices for men with clinically localized prostate carcinoma detected by screening. Cancer. 2000;88(5):1122-1130.
4. O'Rourke ME. Decision making and prostate cancer treatment selection: a review. Semin Oncol Nurs. 2001;17(2):108-117.
5. Kane CJ, Lubeck DP, Knight SJ, et al. Impact of patient educational level on treatment for patients with prostate cancer: data from CaPSURE. Urology. 2003;62(6):1035-1039.
6. Berry DL, Ellis WJ, Woods NF, et al. Treatment decision-making by men with localized prostate cancer: the influence of personal factors. Urol Oncol. 2003;21(2):93-100.
7. Patel HR, Mirsadraee S, Emberton M. The patient's dilemma: prostate cancer treatment choices. J Urol. 2003;169(3):828-833.
8. Kim SP, Knight SJ, Tomori C, et al. Health literacy and shared decision making for prostate cancer patients with low socioeconomic status. Cancer Invest. 2001;19(7):684-691.
9. American Cancer Society: Cancer facts and figures 2004. www. cancer.org/docroot/STT/stt_0.asp. Accessed 11/12/04.
10. American Cancer Society: Detailed guide: prostate cancer, www.cancer.org/docroot/home/index.asp.Accessed 11/12/04.
11. Bott SR, Birtle AJ, Taylor CJ, et al. Prostate cancer management: (1) an update on localized disease. Postgrad Med J. 2003;79(936):575-580.
12. Bott SR, Birtle AJ, Taylor CJ, et al. Prostate cancer management: (2) an update on locally advanced and metastatic disease. Postgrad Med J. 2003;79(937):643-645.
13. Turini M, Redaelli A, Gramegna P, et al. Quality of life and economic considerations in the management of prostate cancer. Pharmacoeconomics. 2003;21(8):527-541.
14. Saigal CS, Litwin MS. The economic costs of early stage prostate cancer. Pharmacoeconomics. 2002;20(13):869-878.
15. Koppie TM, Grossfeld GD, Miller D, et al. Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from The CaPSURE database. Cancer of the Prostate Strategic Urological Research Endeavor. J Urol. 2000;164(1):81-88.
16. Holmberg L, Bill-Axelson A, Helgesen F, et al, Scandinavian Prostatic Cancer Group Study Number 4. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002;347(11):781-789.
17. Cooperberg MR, Broering JM, Litwin MS, et al, CaPSURE Investigators. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. J Urol. 2004;171(4):1393-1401.
18. Penson DF, Schonfeld WH, Flanders SC, et al. Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CAPSURE database. Urology. 2001;57(3):499-503.
19. Taplin SH, Barlow W, Urban N, et al. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst. 1995;87(6):417-426.
20. Knight SJ, Chmiel JS, Kuzel T, et al. Quality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and criterion related validity of 3 measures. J Urol. 1998;160(5):1765-1769.
21. Siston AK, Knight SJ, Slimack NP, et al, Veterans Affairs Cancer of the Prostate Outcomes Study. Quality of life after a diagnosis of prostate cancer among men of lower socioeconomic status: results from the Veterans Affairs Cancer of the Prostate Outcomes Study. Urology. 2003;61(1):172-178.
22. Haas GP, Sakr WA. Epidemiology of prostate cancer. CA Cancer J Clin. 1997;47(5):273-287.
23. Liu L, Cozen W, Bernstein L, et al. Changing relationship between socioeconomic status and prostate cancer incidence. J Natl Cancer Inst. 2001;93(9):705-709.
24. Conlisk EA, Lengerich EJ, Demark-Wahnefried W, et al. Prostate cancer: demographic and behavioral correlates of stage at diagnosis among blacks and whites in North Carolina. Urology. 1999;53(6):1194-1199.
25. Penson DF, Stoddard ML, Pasta DJ, et al. The association between socioeconomic status, health insurance coverage, and quality of life in men with prostate cancer. J Clin Epidemiol. 2001;54(4):350-358.
26. Clark JY, Thompson IM. Military rank as a measure of socioeconomic status and survival from prostate cancer. South Med J. 1994;87(11):1141-1144.
27. Bennett CL, Ferreira MR, Davis TC, et al. Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer. J Clin Oncol. 1998;16(9):3101-3104.
28. Meng MV, Eikin EP, Horion SR, et al. Predictors of treatment after initial surveillance in men with prostate cancer: results from CaPSURE. J Urol. 2003;170 (6 Pt 1):2279-2283.
29. Wilt TJ, Partin MR. Prostate cancer intervention. Involving the patient in early detection and treatment. Postgrad Wed. 2003;114(4):43-49.
30. Pickett M, Bruner DW, Joseph A, et al. Prostate cancer elder alert. Living with treatment choices and outcomes. J Gerontol Nurs. 2000;26(2):22-34.
31. Bruner DW, Pickett M, Joseph A, et al. Prostate cancer elder alert. Epidemiology, screening, and early detection. J Gerontol Nurs. 2000;26(1):6-15.
32. Goolsby MJ. Screening, diagnosis, and management of prostate cancer: improving primary care outcomes. Nurse Pract. 1998;23(3):11-14,16,21-23.
33. Kouriefs C, Georgiou M, Ravi R. Hot flushes and prostate cancer: pathogenesis and treatment. BJU Int. 2002;89(4):379-383,
34. Thompson CA, Shanafelt TD, Loprinzi CL. Andropause: symptom management for prostate cancer patients treated with hormonal ablation. Oncologist. 2003;8(5):474-487.